Cargando…
Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers
BACKGROUND: To date, liver biopsy is the only means of reliable diagnosis for fatty liver disease (FLD). Owing to the inevitable biopsy-associated health risks, however, the development of valid noninvasive diagnostic tools for FLD is well warranted. AIM: We evaluated a particular metabolic profile...
Autores principales: | Siegert, Sabine, Yu, Zhonghao, Wang-Sattler, Rui, Illig, Thomas, Adamski, Jerzy, Hampe, Jochen, Nikolaus, Susanna, Schreiber, Stefan, Krawczak, Michael, Nothnagel, Michael, Nöthlings, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793954/ https://www.ncbi.nlm.nih.gov/pubmed/24130792 http://dx.doi.org/10.1371/journal.pone.0076813 |
Ejemplares similares
-
A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology
por: Helbig, Katherine L, et al.
Publicado: (2012) -
Efficacy assessment of SNP sets for genome-wide disease association studies
por: Wollstein, Andreas, et al.
Publicado: (2007) -
Mutations Causing Complex Disease May under Certain Circumstances Be Protective in an Epidemiological Sense
por: Siegert, Sabine, et al.
Publicado: (2015) -
Genome-wide search for novel human uORFs and N-terminal protein extensions using ribosomal footprinting
por: Fritsch, Claudia, et al.
Publicado: (2012) -
Current software for genotype imputation
por: Ellinghaus, David, et al.
Publicado: (2009)